BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30509302)

  • 1. Epithelial-specific histone modification of the miR-96/182 locus targeting AMAP1 mRNA predisposes p53 to suppress cell invasion in epithelial cells.
    Handa H; Hashimoto A; Hashimoto S; Sugino H; Oikawa T; Sabe H
    Cell Commun Signal; 2018 Dec; 16(1):94. PubMed ID: 30509302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ARF6 and AMAP1 are major targets of
    Hashimoto S; Furukawa S; Hashimoto A; Tsutaho A; Fukao A; Sakamura Y; Parajuli G; Onodera Y; Otsuka Y; Handa H; Oikawa T; Hata S; Nishikawa Y; Mizukami Y; Kodama Y; Murakami M; Fujiwara T; Hirano S; Sabe H
    Proc Natl Acad Sci U S A; 2019 Aug; 116(35):17450-17459. PubMed ID: 31399545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent overexpression of AMAP1, an Arf6 effector in cell invasion, is characteristic of the MMTV-PyMT rather than the MMTV-Neu human breast cancer model.
    Otsuka Y; Oikawa T; Yoshino H; Hashimoto S; Handa H; Yamamoto H; Hashimoto A; Sabe H
    Cell Commun Signal; 2018 Jan; 16(1):1. PubMed ID: 29329590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of mutant KRAS-driven overexpression of ARF6 and MYC by an eIF4A inhibitor drug improves the effects of anti-PD-1 immunotherapy for pancreatic cancer.
    Hashimoto A; Handa H; Hata S; Tsutaho A; Yoshida T; Hirano S; Hashimoto S; Sabe H
    Cell Commun Signal; 2021 May; 19(1):54. PubMed ID: 34001163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-142-3p is downregulated in aggressive p53 mutant mouse models of pancreatic ductal adenocarcinoma by hypermethylation of its locus.
    Godfrey JD; Morton JP; Wilczynska A; Sansom OJ; Bushell MD
    Cell Death Dis; 2018 May; 9(6):644. PubMed ID: 29844410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The PTTG1-targeting miRNAs miR-329, miR-300, miR-381, and miR-655 inhibit pituitary tumor cell tumorigenesis and are involved in a p53/PTTG1 regulation feedback loop.
    Liang HQ; Wang RJ; Diao CF; Li JW; Su JL; Zhang S
    Oncotarget; 2015 Oct; 6(30):29413-27. PubMed ID: 26320179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutant p53 drives invasion in breast tumors through up-regulation of miR-155.
    Neilsen PM; Noll JE; Mattiske S; Bracken CP; Gregory PA; Schulz RB; Lim SP; Kumar R; Suetani RJ; Goodall GJ; Callen DF
    Oncogene; 2013 Jun; 32(24):2992-3000. PubMed ID: 22797073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CIN85, a Cbl-interacting protein, is a component of AMAP1-mediated breast cancer invasion machinery.
    Nam JM; Onodera Y; Mazaki Y; Miyoshi H; Hashimoto S; Sabe H
    EMBO J; 2007 Feb; 26(3):647-56. PubMed ID: 17255943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer.
    Chiyomaru T; Enokida H; Kawakami K; Tatarano S; Uchida Y; Kawahara K; Nishiyama K; Seki N; Nakagawa M
    Urol Oncol; 2012; 30(4):434-43. PubMed ID: 20843712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. rs78378222 polymorphism in the 3'-untranslated region of TP53 contributes to development of age-associated cataracts by modifying microRNA-125b-induced apoptosis of lens epithelial cells.
    Zhao Y; Li X; Zhu S
    Mol Med Rep; 2016 Sep; 14(3):2305-10. PubMed ID: 27431420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRKL oncogene is downregulated by p53 through miR-200s.
    Tamura M; Sasaki Y; Kobashi K; Takeda K; Nakagaki T; Idogawa M; Tokino T
    Cancer Sci; 2015 Aug; 106(8):1033-40. PubMed ID: 26079153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting AMAP1 and cortactin binding bearing an atypical src homology 3/proline interface for prevention of breast cancer invasion and metastasis.
    Hashimoto S; Hirose M; Hashimoto A; Morishige M; Yamada A; Hosaka H; Akagi K; Ogawa E; Oneyama C; Agatsuma T; Okada M; Kobayashi H; Wada H; Nakano H; Ikegami T; Nakagawa A; Sabe H
    Proc Natl Acad Sci U S A; 2006 May; 103(18):7036-41. PubMed ID: 16636290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 Ser15 phosphorylation and histone modifications contribute to IR-induced miR-34a transcription in mammary epithelial cells.
    Wang B; Li D; Kovalchuk O
    Cell Cycle; 2013 Jul; 12(13):2073-83. PubMed ID: 23759592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-300 promotes proliferation and EMT-mediated colorectal cancer migration and invasion by targeting p53.
    Wang L; Yu P
    Oncol Rep; 2016 Dec; 36(6):3225-3232. PubMed ID: 27779716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated analysis of miRNA and mRNA expression profiles in p53-edited PFF cells.
    Qiao C; Liu W; Jiang H; He M; Yang Q; Xing Y
    Cell Cycle; 2020 Apr; 19(8):949-959. PubMed ID: 32213107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth.
    Corney DC; Flesken-Nikitin A; Godwin AK; Wang W; Nikitin AY
    Cancer Res; 2007 Sep; 67(18):8433-8. PubMed ID: 17823410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rab5c promotes AMAP1-PRKD2 complex formation to enhance β1 integrin recycling in EGF-induced cancer invasion.
    Onodera Y; Nam JM; Hashimoto A; Norman JC; Shirato H; Hashimoto S; Sabe H
    J Cell Biol; 2012 Jun; 197(7):983-96. PubMed ID: 22734003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNA-214 enhances the invasion ability of breast cancer cells by targeting p53.
    Wang F; Lv P; Liu X; Zhu M; Qiu X
    Int J Mol Med; 2015 May; 35(5):1395-402. PubMed ID: 25738546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Necessity of p53-binding to the CDH1 locus for its expression defines two epithelial cell types differing in their integrity.
    Oikawa T; Otsuka Y; Onodera Y; Horikawa M; Handa H; Hashimoto S; Suzuki Y; Sabe H
    Sci Rep; 2018 Jan; 8(1):1595. PubMed ID: 29371630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of AMAP1, an ARF6 effector, is associated with elevated levels of PD-L1 and fibrosis of pancreatic cancer.
    Tsutaho A; Hashimoto A; Hashimoto S; Hata S; Kachi S; Hirano S; Sabe H
    Cell Commun Signal; 2020 Jun; 18(1):101. PubMed ID: 32580737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.